Download PDF
J Neurol Surg B Skull Base 2018; 79(02): 117-122
DOI: 10.1055/s-0037-1604363
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Diabetes Insipidus following Endoscopic Transsphenoidal Surgery for Pituitary Adenoma

Abdulrazag M. Ajlan
1   Department of Neurosurgery, Stanford University, Palo Alto, California, United States
2   Department of Neurosurgery, King Saud University, Riyadh, Saudi Arabia
,
Sarah Bin Abdulqader
3   College of Medicine, King Saud University, Riyadh, Saudi Arabia
,
Achal S. Achrol
1   Department of Neurosurgery, Stanford University, Palo Alto, California, United States
,
Yousef Aljamaan
4   College of Medicine, University of Dammam, Dammam, Saudi Arabia
,
Abdullah H. Feroze
1   Department of Neurosurgery, Stanford University, Palo Alto, California, United States
,
Laurence Katznelson
1   Department of Neurosurgery, Stanford University, Palo Alto, California, United States
5   Department of Medicine, Stanford University, Palo Alto, California, United States
,
Griffith R. Harsh
1   Department of Neurosurgery, Stanford University, Palo Alto, California, United States
› Author Affiliations
Further Information

Publication History

26 January 2017

14 June 2017

Publication Date:
03 August 2017 (online)

    Permissions and Reprints

Abstract

Objectives Pituitary adenoma (PA), among the most commonly encountered sellar pathologies, accounts for 10% of primary intracranial tumors. The reported incidence of postoperative diabetes insipidus (DI) is highly variable. In this study, we report our experience with DI following endoscopic transsphenoidal surgery (TSS) for PAs, elucidating the risk factors of postoperative DI, the likelihood of long-term DI, and the impact of DI on the length of stay (LOS).

Methods The study included 178 patients who underwent endoscopic resection of PAs. Early DI was defined as that occurring within the first postoperative week. The mean follow-up was 36 months. Long-term DI was considered as DI apparent in the last follow-up visit.

Results Of the 178 patients included in the study, 77% of the tumors were macroadenomas. Forty-seven patients (26%) developed early DI. Long-term DI was observed in 18 (10.1%) of the full cohort. Age younger than 50 years was significantly associated with a higher incidence of long-term DI (p = 0.02). Macroadenoma and gross total resection were significantly associated with higher incidence of early DI (p = 0.05 and p = 0.04, respectively). The mean LOS was 4 days for patients with early postoperative DI and 3 days for those without it.

Conclusion The reported incidence of postoperative DI is significantly variable. We identified age younger than 50 years a risk factor for developing long-term postoperative DI. Gross total surgical resection and tumor size (> 1 cm) were associated with development of early DI. Early DI increased the LOS on average by 1 day.

Keywords

diabetes insipidus - endoscopic transsphenoidal - pituitary adenoma - postoperative hypernatremia
 

  • References

  • 1 Pinar E, Yuceer N, Imre A, Guvenc G, Gundogan O. Endoscopic endonasal transsphenoidal surgery for pituitary adenomas. J Craniofac Surg 2015; 26 (01) 201-205
    CrossrefPubMedGoogle Scholar
  • 2 Gondim JA, Almeida JP, Albuquerque LA. , et al. Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients. Pituitary 2011; 14 (02) 174-183
    CrossrefPubMedGoogle Scholar
  • 3 Jho H-D, Carrau RL. Endoscopy assisted transsphenoidal surgery for pituitary adenoma. Technical note. Acta Neurochir (Wien) 1996; 138 (12) 1416-1425
    CrossrefPubMedGoogle Scholar
  • 4 Chabot JD, Chakraborty S, Imbarrato G, Dehdashti AR. Evaluation of outcomes after endoscopic endonasal surgery for large and giant pituitary macroadenoma: a retrospective review of 39 consecutive patients. World Neurosurg 2015; 84 (04) 978-988
    CrossrefPubMedGoogle Scholar
  • 5 Berker M, Hazer DB, Yücel T. , et al. Complications of endoscopic surgery of the pituitary adenomas: analysis of 570 patients and review of the literature. Pituitary 2012; 15 (03) 288-300
    CrossrefPubMedGoogle Scholar
  • 6 Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Neurosurg Focus 2010; 29 (04) E5
    CrossrefPubMedGoogle Scholar
  • 7 Charalampaki P, Ayyad A, Kockro RA, Perneczky A. Surgical complications after endoscopic transsphenoidal pituitary surgery. J Clin Neurosci 2009; 16 (06) 786-789
    CrossrefPubMedGoogle Scholar
  • 8 Sheehan JM, Sheehan JP, Douds GL, Page RB. DDAVP use in patients undergoing transsphenoidal surgery for pituitary adenomas. Acta Neurochir (Wien) 2006; 148 (03) 287-291 , discussion 291
    CrossrefPubMedGoogle Scholar
  • 9 Sigounas DG, Sharpless JL, Cheng DM, Johnson TG, Senior BA, Ewend MG. Predictors and incidence of central diabetes insipidus after endoscopic pituitary surgery. Neurosurgery 2008; 62 (01) 71-78 , discussion 78–79
    CrossrefPubMedGoogle Scholar
  • 10 Hensen J, Henig A, Fahlbusch R, Meyer M, Boehnert M, Buchfelder M. Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol (Oxf) 1999; 50 (04) 431-439
    CrossrefPubMedGoogle Scholar
  • 11 Schreckinger M, Walker B, Knepper J. , et al. Post-operative diabetes insipidus after endoscopic transsphenoidal surgery. Pituitary 2013; 16 (04) 445-451
    CrossrefPubMedGoogle Scholar
  • 12 Shah S, Har-El G. Diabetes insipidus after pituitary surgery: incidence after traditional versus endoscopic transsphenoidal approaches. Am J Rhinol 2001; 15 (06) 377-379
    CrossrefPubMedGoogle Scholar
  • 13 Black PM, Zervas NT, Candia GL. Incidence and management of complications of transsphenoidal operation for pituitary adenomas. Neurosurgery 1987; 20 (06) 920-924
    CrossrefPubMedGoogle Scholar
  • 14 Gondim JA, Almeida JP, Albuquerque LA, Gomes EF, Schops M. Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach. World Neurosurg 2014; 82 (1-2): e281-e290
    CrossrefPubMedGoogle Scholar
  • 15 Nemergut EC, Zuo Z, Jane Jr JA, Laws Jr ER. Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients. J Neurosurg 2005; 103 (03) 448-454
    CrossrefPubMedGoogle Scholar
  • 16 Sudhakar N, Ray A, Vafidis JA. Complications after trans-sphenoidal surgery: our experience and a review of the literature. Br J Neurosurg 2004; 18 (05) 507-512
    CrossrefPubMedGoogle Scholar
  • 17 Marić A, Kruljac I, Čerina V, Pećina HI, Šulentić P, Vrkljan M. Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experience. Croat Med J 2012; 53 (03) 224-233
    CrossrefPubMedGoogle Scholar
  • 18 Yano S, Kawano T, Kudo M. , et al. Endoscopic endonasal transsphenoidal approach through the bilateral nostrils for pituitary adenomas. Neurol Med Chir (Tokyo) 2009; 49 (01) 1-7
    CrossrefPubMedGoogle Scholar
  • 19 Bohl MA, Ahmad S, Jahnke H. , et al. Delayed hyponatremia is the most common cause of 30-day unplanned readmission after transsphenoidal surgery for pituitary tumors. Neurosurgery 2016; 78 (01) 84-90
    CrossrefPubMedGoogle Scholar
  • 20 DeKlotz TR, Chia SH, Lu W, Makambi KH, Aulisi E, Deeb Z. Meta-analysis of endoscopic versus sublabial pituitary surgery. Laryngoscope 2012; 122 (03) 511-518
    CrossrefPubMedGoogle Scholar
  • 21 Goudakos JK, Markou KD, Georgalas C. Endoscopic versus microscopic trans-sphenoidal pituitary surgery: a systematic review and meta-analysis. Clin Otolaryngol 2011; 36 (03) 212-220
    CrossrefPubMedGoogle Scholar
  • 22 Schreckinger M, Szerlip N, Mittal S. Diabetes insipidus following resection of pituitary tumors. Clin Neurol Neurosurg 2013; 115 (02) 121-126
    CrossrefPubMedGoogle Scholar
  • 23 Li A, Liu W, Cao P, Zheng Y, Bu Z, Zhou T. Endoscopic versus microscopic transsphenoidal surgery in the treatment of pituitary adenoma: a systematic review and meta-analysis. World Neurosurg 2017; 101: 236-246
    CrossrefPubMedGoogle Scholar
  • 24 Patil CG, Lad SP, Harsh GR, Laws Jr ER, Boakye M. National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002. Neurosurg Focus 2007; 23 (03) E7
    PubMedGoogle Scholar
  • 25 Ajlan A, Zeitouni A, Sirhan D. Internal comparison of open microscopic versus endoscopic approach in trans-sphenoidal surgery. Skull Base 2009; 19 (03) A119 . DOI: 10.1055/s-2009-1242396
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Kristof RA, Rother M, Neuloh G, Klingmüller D. Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study. J Neurosurg 2009; 111 (03) 555-562
    CrossrefPubMedGoogle Scholar
  • 27 Dumont AS, Nemergut II EC, Jane Jr JA, Laws Jr ER. Postoperative care following pituitary surgery. J Intensive Care Med 2005; 20 (03) 127-140
    CrossrefPubMedGoogle Scholar
  • 28 Thomas JG, Gadgil N, Samson SL, Takashima M, Yoshor D. Prospective trial of a short hospital stay protocol after endoscopic endonasal pituitary adenoma surgery. World Neurosurg 2014; 81 (3-4): 576-583
    CrossrefPubMedGoogle Scholar